• About Us
    • Our Leadership Team
    • Our Board
    • Our Operating Partners & Advisors
    • Our Scientific Team
    • Locations
    • Why Us
  • Solutions
    • Solutions

    • Discovery Solutions
      • Integrated Drug Discovery
      • AI & Computational Chemistry
      • Discovery Chemistry
      • Discovery Biology
      • DMPK Services
      • Preclinical Services
    • Development Solutions
      • Process R&D
Services
      • Analytical Services
      • Process Safety
Services
      • In Silico Genotoxicity
    • Manufacturing Services and Solutions
      • Preclinical Supply
Services
      • Clinical Supply
Services
      • Commercial Supply Services
    • ‎
    • Enabling
Technologies
      • Flow Chemistry
      • Biocatalysis
    • New Modalities
      • TPD
        • AUTAC
        • Molecular Glues
        • LYTAC
        • PROTAC
        • Other TPD Modalities
  • Products
    • API Portfolio
  • Careers
  • News & Events
    • News & Events

    • Insights
      • Blogs
      • White Papers
      • Brochures
    • Events
      • Upcoming Events
    • Media
      • Videos
      • Awards
      • Press Release
  • Contact Us
Archimica: Excellence in European API Manufacturing

Archimica: Excellence in European API Manufacturing

by abishek | Oct 25, 2025 | Insights, API, Brochures

Introduction Archimica (a PI Health Sciences company) delivers world-class pharma API manufacturing services, combining quality, reliability, and regulatory excellence. We are a trusted partner for customers worldwide, with 24 Active Drug Master Files in over 50...
Advanced Development & Manufacturing Capabilities

Advanced Development & Manufacturing Capabilities

by abishek | Oct 24, 2025 | Insights, Drug Development, API, Brochures

Introduction PI Health Sciences is your partner for API, intermediate, and KSM manufacturing, from R&D to commercial scale. We offer high-quality, globally compliant solutions. Core Capabilities:> Non-GMP & GMP Manufacturing High Potency (HPAPI) up to OEB4...
PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group

PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group

by abishek | Oct 15, 2025 | Media, API, Press Releases

PI Health Sciences announces the acquisition of Archimica S.p.A from Livia Group April 28, 2023 We are pleased to announce that today PI Health Sciences has acquired Archimica S.p.A (headquarter in Lodi, Italy). PI Health Sciences will provide to Archimica the...
  • Discovery Solutions
    • Integrated Drug Discovery
    • AI & Computational Chemistry
    • Discovery Chemistry
    • Discovery Biology
    • DMPK Services
    • Preclinical Services
  • Development Solutions
    • Process R&D
Services
    • Analytical Services
    • Process Safety
Services
    • In Silico Genotoxicity
  • Manufacturing Solutions
    • Preclinical Supply

    • Clinical Supply

    • Commercial Supply
  • Enabling
Technologies
    • Flow Chemistry
    • Biocatalysis
  • New Modalities
    • TPD
      • AUTAC
      • Molecular Glues
      • LYTAC
      • PROTAC
      • Other TPD Modalities
© 2023 PI Health Sciences Ltd. All rights reserved.

Developed By Luxeveda

  • Privacy Policy
  • Posh Policy
  • Disclaimer
  • Code of Conduct
  • Investors
  • Terms and Conditions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Privacy Policy

Posh Policy

Disclaimer

Code of Conduct

Investors

Terms and Conditions

© 2023 PI Health Sciences Ltd. All rights reserved.

Developed By Luxeveda